73 related articles for article (PubMed ID: 7193669)
1. Radium implant to the parametrium in the treatment of Stage IIIB carcinoma of the cervix: analysis of dosimetry.
Sewchand W; Prempree T; Patanaphan V; Bautro N; Scott RM
Int J Radiat Oncol Biol Phys; 1980 Jul; 6(7):923-6. PubMed ID: 7193669
[No Abstract] [Full Text] [Related]
2. Parametrial implants in the treatment of stage IIIB carcinoma of the cervix. II. Analysis of success and failure.
Prempree T; Patanaphan V; Sewchand W; Scott RM
Cancer; 1980 Sep; 46(6):1485-91. PubMed ID: 7417949
[TBL] [Abstract][Full Text] [Related]
3. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma.
Muschitz S; Petrow P; Briot E; Petit C; De Crevoisier R; Duvillard P; Morice P; Haie-Meder C
Radiother Oncol; 2004 Nov; 73(2):187-94. PubMed ID: 15542166
[TBL] [Abstract][Full Text] [Related]
4. High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: a multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 (study of JASTRO 2006-2007).
Niibe Y; Kenjo M; Onishi H; Ogawa Y; Kazumoto T; Ogino I; Tsujino K; Harima Y; Takahashi T; Anbai A; Tsuchida E; Toita T; Takemoto M; Yamashita H; Hayakawa K
Jpn J Clin Oncol; 2010 Aug; 40(8):795-9. PubMed ID: 20444747
[TBL] [Abstract][Full Text] [Related]
5. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
6. The relationship between milligram-hours and dose to point A in carcinoma of the cervix.
Potish RA; Deibel FC; Khan FM
Radiology; 1982 Nov; 145(2):479-83. PubMed ID: 7134455
[TBL] [Abstract][Full Text] [Related]
7. High-dose-rate interstitial brachytherapy in the management of carcinoma of the uterine cervix and other gynecologic malignancies.
Sitathanee C; Pairatchvet V; Narkwong L; Puataweepong P
J Med Assoc Thai; 2005 Aug; 88(8):1045-50. PubMed ID: 16404830
[TBL] [Abstract][Full Text] [Related]
8. [Value and importance of intracavitary therapy in cervix carcinoma].
Frischkorn R
Strahlenther Onkol; 1986 Jun; 162(6):361-7. PubMed ID: 3738737
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
10. [Rate of complications and dose rate in brachytherapy for carcinoma of the uterine cervix (author's transl)].
Janik I; Bünemann H
Strahlentherapie; 1980 Jul; 156(7):457-65. PubMed ID: 7466878
[TBL] [Abstract][Full Text] [Related]
11. Tumor heterogeneity of FIGO stage III carcinoma of the uterine cervix.
Kim YB; Lee IJ; Kim SY; Kim JW; Yoon HI; Kim SW; Kim S; Kim YT; Suh CO; Kim GE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1323-8. PubMed ID: 19467800
[TBL] [Abstract][Full Text] [Related]
12. Pulsed-dose-rate intracavitary brachytherapy for cervical carcinoma: the AIIMS experience.
Rath GK; Sharma DN; Julka PK; Subramani V; Bahl A; Haresh KP
Am J Clin Oncol; 2010 Jun; 33(3):238-41. PubMed ID: 19841576
[TBL] [Abstract][Full Text] [Related]
13. Californium-252 (252Cf) versus conventional gamma radiation in the brachytherapy of advanced cervical carcinoma long-term treatment results of a randomized study.
Tacev T; Ptácková B; Strnad V
Strahlenther Onkol; 2003 Jun; 179(6):377-84. PubMed ID: 12789463
[TBL] [Abstract][Full Text] [Related]
14. Radium needles implant in the treatment of extensive vaginal involvement from cervical carcinoma. A dosimetry appraisal.
Sewchand W; Prempree T; Patanaphan V; Carbone D; Salazar OM
Acta Radiol Oncol; 1984; 23(6):449-53. PubMed ID: 6099038
[TBL] [Abstract][Full Text] [Related]
15. Gynecologic brachytherapy I: Proper incorporation of brachytherapy into the current multimodality management of carcinoma of the cervix.
Nori D; Dasari N; Allbright RM
Semin Radiat Oncol; 2002 Jan; 12(1):40-52. PubMed ID: 11813150
[TBL] [Abstract][Full Text] [Related]
16. In-vivo dosimetry for gynaecological brachytherapy: physical and clinical considerations.
Waldhäusl C; Wambersie A; Pötter R; Georg D
Radiother Oncol; 2005 Dec; 77(3):310-7. PubMed ID: 16226818
[TBL] [Abstract][Full Text] [Related]
17. Calculation of radiation doses in critical organs compared with in vivo dosimetry during brachytherapy of carcinoma of the uterine cervix.
Rasovská O; Ott O; Strnad V; Tacev T
Neoplasma; 1990; 37(2):205-11. PubMed ID: 2342633
[TBL] [Abstract][Full Text] [Related]
18. Long term follow-up results of high-dose rate remote afterloading intracavitary radiation therapy for carcinoma of the uterine cervix.
Chatani M; Matayoshi Y; Masaki N; Teshima T; Inoue T
Strahlenther Onkol; 1994 May; 170(5):269-76. PubMed ID: 8197549
[TBL] [Abstract][Full Text] [Related]
19. Dosimetry and complication rate in the treatment of cervix carcinoma with external irradiation and brachytherapy.
Kuipers T
Sonderb Strahlenther Onkol; 1988; 82():127-31. PubMed ID: 3134708
[No Abstract] [Full Text] [Related]
20. [Determination of spatial distributions of the total dose in the combination of teletherapy with contact therapy. 2. The influence of position changes of the contact therapy applicator on the total dose distribution in unoperated cervix carcinoma].
Ehrhardt M; Voigtmann L
Radiobiol Radiother (Berl); 1980 Oct; 21(5):677-85. PubMed ID: 7208856
[No Abstract] [Full Text] [Related]
[Next] [New Search]
